INNOVATION1 BIOTECH INC. Stock-Based Compensation
INNOVATION1 BIOTECH INC. reported Stock-Based Compensation of $103.00 thousand for the 12-month period ending 2023-08-31, per its 10-K filed 2024-01-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-05-06
- INNOVATION1 BIOTECH INC. share-based payment arrangement, expense for the quarter ending 2022-02-28 was $0.00.
- INNOVATION1 BIOTECH INC. share-based payment arrangement, expense for the quarter ending 2021-02-28 was $0.00.
- INNOVATION1 BIOTECH INC. share-based payment arrangement, expense for fiscal 2023 was $103.00K.
- INNOVATION1 BIOTECH INC. share-based payment arrangement, expense for fiscal 2022 was $0.00.
- INNOVATION1 BIOTECH INC. share-based payment arrangement, expense for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- INNOVATION1 BIOTECH INC. share-based payment arrangement, expense for fiscal 2019 was $18.77K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|
| 2023-08-31 | $103.00K 10-K · filed 2024-01-17 | ||
| 2023-02-28 | $22.50K 10-Q · filed 2025-05-06 | ||
| 2022-08-31 | $0.00 10-K · filed 2024-01-17 | ||
| 2022-02-28 | $0.00 10-Q · filed 2022-04-15 | $0.00 10-Q · filed 2022-04-15 | |
| 2021-02-28 | $0.00 10-Q · filed 2022-04-15 | $0.00 10-Q · filed 2022-04-15 | |
| 2020-08-31 | $0.00 10-K · filed 2020-12-15 | ||
| 2019-08-31 | $18.77K 10-K · filed 2020-12-15 |